Assessment of methylphenidate-induced changes in binding of continuously infused [11C]-raclopride in healthy human subjects: correlation with subjective effects
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Rationale The dopaminergic system has been implicated in the pathogenesis and treatment of a variety of neuropsychiatric disorders. It has been shown that information on endogenous dopamine (DA) release can be obtained noninvasively by combining positron emission tomography with a dopaminergic challenge. This approach is based on the assumption that an injected radiolabeled ligand competes with the neurotransmitter for the same receptor. Increases in DA release will therefore result in a decreased binding of the radioligand.Objectives We investigated the effect of the DA reuptake blocker methylphenidate (MP) on the binding of the D(2) receptor ligand [(11)C]-raclopride (RAC).Methods The effect of a 0.25 mg/kg intravenous dose of MP was studied in six healthy volunteers. RAC was administered as a bolus followed by constant infusion, and subjective effects were assessed using verbal rating scales.Results Control scans without MP administration showed that the mean RAC binding reached stable values approximately 30 min after start of the infusion. MP administration induced a 24% decrease in RAC binding in the total striatum. Correlations were found between the MP-induced change in euphoria and the percent change in binding potential (DeltaBP) in the dorsal striatum and between baseline anxiety and DeltaBP in the dorsal and middle striatum. We also found a negative correlation between baseline BP in the dorsal striatum and change in euphoria.Conclusions Our results comply with previous findings, indicating the feasibility of the bolus infusion design combined with a relatively low MP dose to study dopaminergic (dys)function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“DA release, especially in the striatum, has been implicated in the process of rewarding or reinforcing effects of certain stimuli (Ikemoto and Panksepp 1999; McClure et al. 2004; Spanagel and Weiss 1999; Ungless 2004; Wise 2004).”
BackgroundSeparate neural systems value immediate and delayed monetary rewards
McClure, S. M., Laibson, D. I., Loewenstein, G., & Cohen, J. D. (2004) · Science · doi:10.1126/science.1100907 · Cited by 3,089
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813 · cited 1×
“The involvement of dopamine (DA) in these disorders may be related to its function in reward processing (Kapur 2003; Kunig et al. 2000; Schmidt et al. 2001).”
BackgroundIkemoto, S., & Panksepp, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00023-5 · Cited by 1,450
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease
de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001) · Science · doi:10.1126/science.1060937 · Cited by 991
The dopamine hypothesis of reward: past and current status
Spanagel, R., & Weiss, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01447-2 · Cited by 973
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Pruessner, J. C., Champagne, F., Meaney, M. J., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3422-03.2004 · Cited by 709 · cited 1×
“Using this method, correlations between DA function and behavioral or physiological scores have been found, providing information on the possible role of this neurotransmitter in pathological or physiological processes (Drevets et al. 2001; Laruelle et al. 1995; Leyton et al. 2002; Martinez et al. 2003; Pruessner et a…”
MethodAmphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706 · cited 9×
“studies reported correlations between subjective effects and changes in ligand binding (Drevets et al. 2001; Laruelle et al. 1995; Leyton et al. 2002; Martinez et al. 2003; Volkow et al. 1994, 1999a).”
BackgroundMethodResultInfluentialHalf a century of antipsychotics and still a central role for dopamine D2 receptors
Kapur, S., & Mamo, D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.004 · Cited by 638 · cited 1×
“The dopaminergic system has been implicated in the pathogenesis and treatment of a variety of neurological and psychiatric disorders, such as schizophrenia, Parkinson’s disease, depression, and addiction (Kapur and Mamo 2003; Leenders 2002; Naranjo et al. 2001; Volkow et al. 2002a).”
BackgroundSmall, D. M., Jones-Gotman, M., & Dagher, A. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00253-2 · Cited by 632
Kuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623 · cited 1×
“Microdialysis studies have shown that both compounds induce large increases in DA levels (Breier et al. 1997; Hernandez et al. 1987; Hurd and Ungerstedt 1989; Kuczenski and Segal 1997), which resulted in 15–25% reductions in RAC binding in human subjects after intravenous administration (Breier et al.”
BackgroundMartinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525
Leyton, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00366-4 · Cited by 476
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Wong, C., Hitzemann, R., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35115-8 · Cited by 422
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Gifford, A., Hitzemann, R., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1440 · Cited by 406
Volkow, N. D., Wang, G.-J., Fowler, J. S., Hitzemann, R., Angrist, B., Gatley, S. J., Logan, J., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.19 · Cited by 405
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00008 · Cited by 398
Imaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379
Carson, R. E., Channing, M. A., Blasberg, R. G., Dunn, B. B., Cohen, R. M., Rice, K. C., & Herscovitch, P. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.6 · Cited by 375
SPECT imaging of striatal dopamine release after amphetamine challenge.
Laruelle, M. A., Abi‐Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., & Kung, H. F. (1995) · PubMed · Cited by 333
Dopamine release in human ventral striatum and expectation of reward
de la Fuente-Fernández, R., Phillips, A. G., Zamburlini, M., Sossi, V., Calne, D. B., Ruth, T. J., & Stoessl, A. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00130-4 · Cited by 319
Oswald, L. M., Wong, D. F., McCaul, M., Zhou, Y., Kuwabara, H., Choi, L., Brasic, J., & Wand, G. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300667 · Cited by 314
Dopamine receptors in human brain: Autoradiographic distribution of D2 sites
Camps, M., Cortés, R., Gueye, B., Probst, A., & Palacios, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90179-6 · Cited by 305
Dewey, S. L., Smith, G. S., Logan, J., Brodie, J. D., Fowler, J. S., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890130407 · Cited by 283
Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study
Volkow, N. D., Wang, G., Fowler, J. S., Thanos, P., Logan, J., Gatley, S. J., Gifford, A., Ding, Y., Wong, C., & Pappas, N. (2002) · Synapse · doi:10.1002/syn.10137 · Cited by 275
Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans
Laruelle, M. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00043-2 · Cited by 266
The role of the brain reward system in depression
Naranjo, C. A., Tremblay, L. K., & Busto, U. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00156-7 · Cited by 245
Dopamine Transmission in the Human Striatum during Monetary Reward Tasks
Zald, D. H., Boileau, I., El-Dearedy, W., Gunn, R., McGlone, F., Dichter, G. S., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4643-03.2004 · Cited by 238 · cited 1×
“In our study, we have found a correlation between the MP-induced change in euphoria and BP change in the dorsal striatum, which agrees with findings from previous studies with MP and studies using nondrug challenges (Barrett et al. 2004; De la Fuente Fernandez et al. 2001; Small et al. 2003; Volkow et al. 1999a; Zald…”
ResultQuantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion
Carson, R. E., Breier, A., de Bartolomeis, A., Saunders, R. C., Su, T. P., Schmall, B., Der, M. G., Pickar, D., & Eckelman, W. C. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199704000-00009 · Cited by 237
Lidow, M. S., Goldman-Rakic, P. S., Rakic, P., & Innis, R. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6412 · Cited by 209
Methylphenidate, Dextroamphetamine, and Levamfetamine: Effects on Schizophrenic Symptoms
Janowsky, D. S. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030024003 · Cited by 205
Ungless, M. A. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.10.001 · Cited by 192
Barrett, S. P., Boileau, I., Okker, J., Pihl, R. O., & Dagher, A. (2004) · Synapse · doi:10.1002/syn.20066 · Cited by 173
Ito, H., Hietala, J., Blomqvist, G., Halldin, C., & Farde, L. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199809000-00003 · Cited by 158
Endogenous dopamine release after pharmacological challenges in Parkinson's disease
Piccini, P., Pavese, N., & Brooks, D. J. (2003) · Annals of Neurology · doi:10.1002/ana.10526 · Cited by 147
In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen
Hurd, Y. L., & Ungerstedt, U. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90066-6 · Cited by 144
Hernandez, L., Lee, F., & Hoebel, B. G. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90047-5 · Cited by 120
Volkow, N. D., Wang, G., Fowler, J. S., Molina, P. E., Logan, J., Gatley, S. J., Gifford, A. J., Ding, Y., Wong, C., Pappas, N. R., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1340-7 · Cited by 119
Schmidt, K., Nolte-Zenker, B., Patzer, J., Bauer, M., Schmidt, L. G., & Heinz, A. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15184 · Cited by 107
Sun, W., Ginovart, N., Ko, F., Seeman, P., & Kapur, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.456 · Cited by 99
Pet physiological measurements using constant infusion
Carson, R. E. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00138-4 · Cited by 96
Tsukada, H., Miyasato, K., Kakiuchi, T., Nishiyama, S., Harada, N., & Domino, E. F. (2002) · Synapse · doi:10.1002/syn.10102 · Cited by 91
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
Kegeles, L. S., Zea‐Ponce, Y., Abi‐Dargham, A., Rodenhiser, J., Wang, T., Weiss, R., Heertum, R. L. V., Mann, J. J., & Laruelle, M. A. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4<302::aid-syn9>3.0.co;2-a · Cited by 87
Ehrin, E., Gawell, L., Högberg, T., de Paulis, T., & Ström, P. (1987) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2580240808 · Cited by 86
Reduced reward processing in the brains of Parkinsonian patients
Künig, G., Leenders, K. L., Martin-Sölch, C., Missimer, J., Magyar, S., & Schultz, W. (2000) · NeuroReport · doi:10.1097/00001756-200011270-00019 · Cited by 85
Booij, J., Korn, P., Linszen, D. H., & van Royen, E. A. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00841408 · Cited by 77
Wang, G.-J., Volkow, N. D., Hitzemann, R. J., Wong, C., Angrist, B., Burr, G., Pascani, K., Pappas, N., Lu, A., Cooper, T., et al. (1997) · European Addiction Research · doi:10.1159/000259147 · Cited by 70
Slifstein, M., Narendran, R., Hwang, D., Sudo, Y., Talbot, P. S., Huang, Y. H., & Laruelle, M. A. (2004) · Synapse · doi:10.1002/syn.20062 · Cited by 68
Nicotine-Induced Dopamine Release in Primates Measured with [11C]Raclopride PET
Marenco, S., Carson, R. E., Berman, K. F., Herscovitch, P., & Weinberger, D. R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300287 · Cited by 66
Marsteller, D. A., Gerasimov, M. R., Schiffer, W. K., Geiger, J., Barnett, C. R., Borg, J. S., Scott, S., Ceccarelli, J., Volkow, N. D., Molina, P. E., et al. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00288-9 · Cited by 64
Zaidi, H., Montandon, M., & Slosman, D. O. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1325-8 · Cited by 36
Rottenberg, D. A., Moeller, J. R., Strother, S. C., Dhawan, V., & Sergi, M. L. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.42 · Cited by 30
Bergström, M., Böhm, C., Ericson, K., Eriksson, L., & Litton, J.-E. (1980) · IEEE Transactions on Nuclear Science · doi:10.1109/tns.1980.4330887 · Cited by 28
Endocrine and behavioural responses to methylphenidate in depression
Joyce, P. R., Donald, R. A., Nicholls, M. G., Livesey, J. H., & Abbott, R. M. (1986) · Psychological Medicine · doi:10.1017/s0033291700010291 · Cited by 12
Disease process and drug treatments in Parkinson's disease
Leenders, K. L. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00106-2 · Cited by 12
Human dopamine response to drugs and natural rewards
Dagher, A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9591524.0717 · Cited by 1
Cited by
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“…in ligand binding potential in PET studies (Booij et al., 1997; Clatworthy et al., 2009; Montgomery et al., 2007; Spencer et al., 2006, 2010; Udo de Haes et al., 2005; Volkow et al., 1994, 2001, 2004; Wang et al., 1999), with evidence to indicate that this effect is related to binding to the DAT…”
InfluentialIncreased Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine Craving
Wong, D. F., Kuwabara, H., Schretlen, D. J., Bonson, K. R., Zhou, Y., Nandi, A., Brašić, J. R., Kimes, A. S., Maris, M. A., Kumar, A., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301194 · Cited by 311
Clatworthy, P. L., Lewis, S. J. G., Brichard, L., Hong, Y. T., Izquierdo, D., Clark, L., Cools, R., Aigbirhio, F. I., Baron, J.-C., Fryer, T. D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3266-08.2009 · Cited by 229
“…which reported that D-amphetamine in humans (Drevets et al., 2001; Martinez et al., 2003) and in the baboon (Drevets et al., 1999), as well as intravenous methylphenidate in humans (Udo de Haes et al., 2005), produced the greatest overall changes in BP in ventral striatum and putamen.”
BackgroundInvestigating the Dopaminergic Synapse In Vivo. I. Molecular Imaging Studies in Humans
Nikolaus, S., Antke, C., Kley, K., Poeppel, T. D., Hautzel, H., Schmidt, D., & Müller, H. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.6.439 · Cited by 51
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD
Fan, X., & Hess, E. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.011 · Cited by 55
“…comparable increases in extracellular dopamine in humans as assessed by positron emission tomography (PET) imaging of psychostimulant-induced displacement of [11C]raclopride binding (Breier et al., 1997; Volkow et al., 2001; Cardenas et al., 2004; Oswald et al., 2005; Udo de Haes et al., 2005).”
Background
Metadata
- Authors
- Udo de Haes, J. I., Kortekaas, R., Van Waarde, A., Maguire, R. P., Pruim, J., & den Boer, J. A.
- Affiliations
- University Medical Center Groningen (NL)
- Venue
- Psychopharmacology
- Published
- 2005-10-12
- Volume
- 183
- Issue
- 3
- Pages
- 322-330
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2103399368
- Cited by
- 18
- References
- 63
- Citations by year
- 2026: 1 · 2023: 1 · 2021: 2 · 2019: 1 · 2018: 1 · 2014: 2 · 2012: 1
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methylphenidate, [11C]raclopride, dopamine release, striatum, euphoria, anxiety, subjective effects, binding potential, bolus infusion
- MeSH terms
- Adolescent, Adult, Blood Pressure, Carbon Radioisotopes, Female, Heart Rate, Humans, Male, Methylphenidate, Receptors, Dopamine D2, Raclopride, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.